Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
Beacon
®
Optofluidic System
Beacon Select™ Optofluidic System
The Lightning
®
Optofluidic System
Culture Station™ System
Technology
Company
TechAccess Subscriptions
Innovation Centers
News & Articles
Press Releases
Events
Company
Investor Relations
Careers
Customer Spotlights
Publications
Careers
Resources
Support
Get In Touch
Latest
News
News
09.13.20
Q&A: Distributed Biological Processing Can Prevent Pandemics
News
09.11.20
Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion
News
08.12.20
Health Care CEO Does 180 Zoom Calls In Three Days to Help Take Company Public
News
08.11.20
A Singular View of COVID-19
News
08.04.20
Samsung Biologics Launches S-CHOice Cell Line Expression Technology
News
07.22.20
Light-Based Chips Speed up Cell-Line Development for GSK
News
07.20.20
Berkeley Lights flies high with $178M IPO
News
07.17.20
Berkeley Lights, Inc. Rings the Opening Bell in Celebration of its IPO
News
06.17.20
As We Wait for a Vaccine, Scientists Work to Scale Up the Best COVID-19 Antibodies to Give New Patients
News
06.16.20
Get to IND Faster: Accelerated and High-Performance Cell-Line Development
News
06.15.20
Optofluidics Aids Cell Line Development for Antibody-Based Therapies
News
06.11.20
Antibody Therapies to Cure Coronavirus Now Under Human Trial Phase
News
05.21.20
Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab
News
05.13.20
The Race Is On to Find the Holy Grail of Covid-19 Antibodies
News
05.11.20
Antibody Shots Could Give Short-Term Doses of COVID-19 Protection. Will They Arrive before a Vaccine?
News
05.08.20
The Hope behind Antibody Treatments as a Quick Coronavirus Fix
News
05.06.20
How to Prevent Another COVID-19? ‘Invest in Infrastructure’
News
05.05.20
Finding the Best Cells for Faster Drug Discovery
‹
1
2
3
›
»